Last updated at 22 Jun 2024 02:33 PM
Director
DIN: 08902607
Prafful Agarwal is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at HUMBLE LIFESCIENCES & AYURVEDA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08902607.Prafful Agarwal is currently involved in 2 different roles. Their most recent position is with HNV PHARMA LIMITED as a Individual Promoter. The first company Prafful Agarwal was appointed to as a director was HUMBLE LIFESCIENCES & AYURVEDA PRIVATE LIMITED. Prafful Agarwal is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Prafful Agarwal is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at HUMBLE LIFESCIENCES & AYURVEDA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08902607.Prafful Agarwal is currently involved in 2 different roles. Their most recent position is with HNV PHARMA LIMITED as a Individual Promoter. The first company Prafful Agarwal was appointed to as a director was HUMBLE LIFESCIENCES & AYURVEDA PRIVATE LIMITED. Prafful Agarwal is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1 Year 6 Months Interval
Company Name | Designation | Date of Appointment |
---|---|---|
HUMBLE LIFESCIENCES & AYURVEDA PRIVATE LIMITED | Director | 21-Oct-2020 |
HUMBLE LIFESCIENCES & AYURVEDA PRIVATE LIMITED | Individual Promoter | 21-Oct-2020 |
HNV PHARMA LIMITED | Individual Promoter | 28-Sep-2021 |
HNV PHARMA LIMITED | Director | 28-Sep-2021 |